Hap Trading, LLC Ampio Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$0.08 - $21.0 $1,608 - $422,100	-20,100 Reduced 22.61%	68,800 $0
Q2 2022 Aug 12, 2022	BUY	$0.16 - $0.47 $5,776 - $16,967	36,100 Added 68.37%	88,900 $1,000
Q1 2022 May 12, 2022	BUY	$0.42 - $0.62 $16,002 - $23,622	38,100 Added 259.18%	52,800 $5,000
Q4 2021 Feb 14, 2022	SELL	$0.56 - $1.71 $3,248 - $9,918	-5,800 Reduced 28.29%	14,700 $2,000
Q3 2021 Nov 10, 2021	BUY	$1.21 - $1.8 $1,815 - $2,700	1,500 Added 7.89%	20,500 $2,000
Q2 2021 Aug 11, 2021	SELL	$1.56 - $1.98 $11,544 - $14,652	-7,400 Reduced 28.03%	19,000 $1,000
Q1 2021 May 14, 2021	SELL	$1.36 - $2.49 $85,952 - $157,368	-63,200 Reduced 70.54%	26,400 $9,000
Q4 2020 Feb 16, 2021	BUY	$0.75 - $2.76 $34,500 - $126,959	46,000 Added 105.5%	89,600 $36,000
Q3 2020 Nov 13, 2020	BUY	$0.61 - $1.17 $427 - $819	700 Added 1.63%	43,600 $9,000
Q2 2020 Aug 10, 2020	SELL	$0.47 - $0.72 $4,794 - $7,344	-10,200 Reduced 19.21%	42,900 $10,000
Q1 2020 May 08, 2020	BUY	$0.36 - $0.74 $4,500 - $9,250	12,500 Added 30.79%	53,100 $9,000
Q4 2019 Feb 11, 2020	BUY	$0.35 - $0.58 $14,210 - $23,548	40,600 New	40,600 $8,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.